Support Care Cancer[removed]:104–108 DOI[removed]s00520[removed]

First Page		Document Content
Date: 2012-07-02 09:26:39 Organic chemistry Chemotherapy-induced nausea and vomiting Ondansetron 5-HT3 antagonist NK1 receptor antagonist Dolasetron Dexamethasone Palonosetron Metoclopramide Chemistry Medicine Antiemetics		Support Care Cancer[removed]:104–108 DOI[removed]s00520[removed] Add to Reading List Source URL: www.mascc.org Download Document from Source Website File Size: 107,33 KB Share Document on Facebook

	P11444 - ASCO2014 MEC and HEC DocID: 1a4Ek - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 19OCx - View Document
	Astellas Receives Approval for a Supplemental New Drug Application for Irribow®/Irribow® OD, a Treatment of Diarrhea-predominant Irritable Bowel Syndrome, in Japan Tokyo, May 26, Astellas Pharma Inc. (“Astella DocID: 19AF1 - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 199Dl - View Document
	P11444 - ASCO2014 MEC and HEC DocID: 1987o - View Document